Diseases of the thoracic aorta—particularly acute Stanford Type B aortic dissection and complex aortic arch aneurysms—represent life-threatening medical emergencies where traditional open surgical repair requires deep hypothermic circulatory arrest, median sternotomy, and carries elevated mortality and stroke risks. While standard Thoracic Endovascular Aortic Repair (TEVAR) transformed descending aortic care, pathologies involving the aortic arch branches (Zones 0–2) historically posed formidable anatomical barriers. Based in Shanghai’s Zhangjiang Hi-Tech Park, Endovastec (心脉医疗, MicroPort Endovascular) broke this global clinical deadlock by developing the Castor® Branched Aortic Stent-Graft System—the world's first commercially approved unibody branched aortic stent-graft—alongside the next-generation Hector™ Multi-Branched Thoracic Stent-Graft System.
For international cardiovascular institute directors, chiefs of vascular surgery, and specialized medical device distributors seeking to acquire world-leading aortic endovascular technologies, China Medical Concierge – Shanghai (CMCS) provides comprehensive on-ground procurement navigation and clinical liaison services in Shanghai.
1. Core Clinical Breakthroughs & Anatomic Indications
Endovastec’s proprietary branched stent-graft systems overcome the severe limitations of off-label "chimney," "fenestration," or hybrid debranching techniques:
Castor® Unibody Branched Stent-Graft System
- First-in-Class Integrated Unibody Construction: The branch graft and the main stent-graft body are seamlessly woven as a single unit without mechanical junction seams, eliminating the persistent risk of Type Ia/Type III gutter endoleaks and branch displacement common to parallel chimney techniques.
- Preservation of the Left Subclavian Artery (LSA): Specifically engineered for aortic pathologies where the proximal landing zone encroaches on Zone 2. It reconstructs the LSA while sealing the primary proximal entry tear in acute/chronic Type B dissections, preserving posterior cerebral perfusion and left arm blood flow.
- Minimally Invasive Delivery: Deployed via a single femoral artery access paired with a left brachial guidewire traction technique, drastically reducing operative duration, systemic heparinization, and intensive care stay.
Hector™ Multi-Branched Thoracic Stent-Graft (The Triple-Branch Solution)
- Total Endovascular Aortic Arch Reconstruction (Zone 0/1): Engineered to address lesions involving the innominate artery and left common carotid artery (LCCA), Hector™ provides a modular multi-branched architecture allowing complete endovascular repair of the ascending aorta and transverse arch without open thoracotomy.
2. Premier Shanghai Hospitals & Vascular Surgical Teams Utilizing Endovastec
Shanghai is home to the world’s most renowned high-volume vascular surgery and aortic interventional centers, where Castor® and Hector™ were rigorously pioneered and standardized:
-
Shanghai Zhongshan Hospital (Fudan University)
Department of Vascular Surgery: Recognized globally as the foremost pioneer in endovascular aortic repair in China. Zhongshan’s vascular surgical team served as principal investigators for the landmark clinical multicenter trials of the Castor® system, establishing global procedural protocols and publishing long-term follow-up data demonstrating exceptional branch patency and freedom from reintervention. -
Shanghai Changhai Hospital (Naval Medical University)
Department of Vascular Surgery: A leading national center for complex aortic emergencies and deep arch reconstruction, Changhai’s vascular team routinely performs high-difficulty branched and fenestrated endovascular repairs for complex dissecting aneurysms. -
Shanghai DeltaHealth Hospital (德达医院)
Heart & Vascular Center: Renowned for high-acuity cardiovascular surgery, multi-branch aortic stent-graft implantation, and international clinical pathways for overseas patients.
3. Procurement Advantages for Overseas Buyers & Cardiac Centers
- Unrivaled Clinical Differentiation: Castor® remains one of the world's few commercially proven unibody branched stent systems, offering hospital vascular departments a distinct clinical superiority over conventional straight grafts and makeshift chimney techniques.
- High-Value Implant Profitability: Premium Class III implantable devices with favorable global pricing structures compared to legacy multinational products, offering robust operating margins for specialized distributors and private cardiovascular networks.
- Comprehensive Global Regulatory Footprint: Backed by extensive multicenter clinical trial evidence, CE MDR registration, US FDA Breakthrough Device Designation, and clinical approvals across more than 90 countries and regions worldwide (supported commercially in Europe through Endovastec's subsidiary Lombard Medical).
- Rapid Customization & Sizing Verification: Supported by dedicated 3D vascular reconstruction modeling and rapid sterile delivery protocols from Shanghai bonded logistics hubs.
4. How CMCS Empowers International Procurement Committees
Procuring advanced Class III implantable aortic technologies demands rigorous clinical due diligence, proctoring access, and seamless supply-chain coordination. CMCS provides an authoritative bridge in Shanghai:
- Surgical Observation & Case-Planning Peer Exchanges: We coordinate on-ground observation inside hybrid operating theaters at Shanghai’s top vascular centers (e.g., Zhongshan, Changhai), allowing visiting vascular surgeons to witness live Castor® branch wire-capture and deployment techniques alongside master Chinese proctors.
- Manufacturing Plant & Cleanroom Audits: CMCS arranges technical site visits to Endovastec’s GMP cleanrooms and R&D testing facilities in Zhangjiang, Shanghai, verifying stent radial-force testing, laser micro-welding, and graft weaving quality standards.
- Direct Commercial & Distributor Agreement Negotiation: We connect international buyers directly with Endovastec’s global commercial leadership and authorized export divisions, securing uninflated factory-direct pricing, distributor territory protections, and consignment stock arrangements.
- Sterile Logistics, Cold-Chain & Regulatory Dossier Support: We coordinate export compliance through the Shanghai Free Trade Zone, assisting distributors with CE technical documentation, local Ministry of Health registration dossiers, and proctor training agreements.
Compliance & Regulatory Notice
China Medical Concierge – Shanghai (CMCS) is an independent healthcare management and medical procurement navigation consultancy based in Shanghai. CMCS is not a medical device manufacturer, licensed distributor, or healthcare facility. We facilitate on-ground technical evaluations, clinical site visits, and commercial communication channels. All commercial supply agreements, regulatory filings, product warranties, and international logistics are executed directly between the purchaser and the certified original equipment manufacturer (OEM) or its licensed export trade partners in compliance with international trade laws.
Initiate a Consultation or Clinical Site Visit in Shanghai
To schedule an observation of branched aortic procedures in Shanghai, coordinate a factory audit at Endovastec's Zhangjiang headquarters, or request technical product specifications and export packages, please contact our international procurement office:
- Email: contract@medicalsh.com
- WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
- Website: www.medicalsh.com
0 comments